Poly-α(1→4)glucopyranose-based matrices with hydrazide crosslinking
US8790701B2 · kind B2 · utility
2Cited by
13References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2009 |
| Grant date | Jul 29, 2014 |
| Priority date | — |
| Expiry date | Jan 19, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08B31/185
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides biocompatible, biodegradable matrices formed from poly-α(1→4)glucopyranose and reactive hydrazide groups. The matrices can be used for various applications in the body, including drug delivery and cell therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.